Mind Medicine Inc (MNMD) Stock: What the Analysts are Saying
The stock has a 36-month beta value of -6.80. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as
The stock has a 36-month beta value of -6.80. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as
The stock price of Mind Medicine Inc (NASDAQ: MNMD) has dropped by -0.83 compared to previous close of 8.46. Despite this, the company has seen
The stock price of Mind Medicine Inc (NASDAQ: MNMD) has dropped by -2.52 compared to previous close of 9.53. Despite this, the company has seen
Mind Medicine Inc (NASDAQ: MNMD)’s stock price has plunge by -7.71relation to previous closing price of 10.89. Nevertheless, the company has seen a 2.03% surge
In the past week, MNMD stock has gone up by 20.99%, with a monthly gain of 91.19% and a quarterly surge of 229.56%. The volatility
The economic climate has been particularly detrimental to blue-chip stocks in the past, as well as to stocks under $1, particularly during the peak of
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.